Mindfulness-based Cognitive Therapy for People With Parkinson's Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Parkinson Disease
- Sponsor
- University of California, San Francisco
- Enrollment
- 16
- Locations
- 1
- Primary Endpoint
- Change in anxiety symptom severity
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease.
Detailed Description
An adapted MBCT intervention will be offered to people with Parkinson's disease and mild-to-moderate depression and/or anxiety. Two 8-week long MBCT groups will be held between September 2019 and March 2020, based on the adapted protocol. Modifications will include shortening the traditional 120-minute to 90-minute format and performing mindful yoga from a chair, instead of a floor mat. Participants will be recruited from the community, according to the eligibility criteria detailed below. The participants' pre- and post-MBCT anxiety and/or depressive symptom severity and mindfulness levels (as measured with standardized, validated scales) will be compared, using a paired t-test.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of Parkinson's disease or parkinsonism (established by a neurologist)
- •Living in the San Francisco Bay Area
- •Being able and willing to attend 8 weekly 90-minute group sessions
- •Mild-to-moderate anxiety: GAD-7 score ≤ 16
- •Mild-to-moderate depression: PHQ-9 score ≤ 18
Exclusion Criteria
- •Severe anxiety: GAD-7 score \> 16
- •Moderately severe-to-severe depression: PHQ-9 score \> 18
- •Cognitive impairment: Montreal Cognitive Assessment (MoCA) score \< 24
- •Heavy alcohol or drug use
- •Severe psychosis
- •Active suicidal or homicidal ideation
- •Severe motor fluctuations (less than 2 hours "on" time per day)
Outcomes
Primary Outcomes
Change in anxiety symptom severity
Time Frame: From pre- to post-MBCT 8 weeks later
Change in Generalized Anxiety Disorder-7 item score (for participants with anxiety). The scale score range is 0-21, with higher scores indicating more severe anxiety.
Change in depressive symptom severity
Time Frame: From pre- to post-MBCT 8 weeks later
Change in Patient Health Questionnaire-9 score (for participants with depression). The scale score range is 0-27, with higher scores indicating more severe depression.
Secondary Outcomes
- Change in mindfulness levels(From pre- to post-MBCT 8 weeks later)
- Time spent practicing mindfulness(During MBCT group (8 week-period))